Abstract Lipid nanoparticles based on solid matrix have emerged as potential drug carriers to improve gastrointestinal (GI) absorption and oral bioavailability of several drugs, especially lipophilic compounds. These formulations may also be used for sustained drug release. Solid lipid nanoparticle (SLN) and the newer generation lipid nanoparticle, nanostructured lipid carrier (NLC), have been studied for their capability as oral drug carriers. Biodegradable, biocompatible, and physiological lipids are generally used to prepare these nanoparticles. Hence, toxicity problems related with the polymeric nanoparticles can be minimized. Furthermore, stability of the formulations might increase than other liquid nano-carriers due to the solid matrix of these lipid nanoparticles. These nanoparticles can be produced by different formulation techniques. Scaling up of the production process from lab scale to industrial scale can be easily achieved. Reasonably high drug encapsulation efficiency of the nanoparticles was documented. Oral absorption and bioavailability of several drugs were improved after oral administration of the drug-loaded SLNs or NLCs. In this review, pros and cons, different formulation and characterization techniques, drug incorporation models, GI absorption and oral bioavailability enhancement mechanisms, stability and storage condition of the formulations, and recent advances in oral delivery of the lipid nanoparticles based on solid matrix will be discussed.
physiological       0.624959862321166^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Physiology            

toxicity                      1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Toxicity              

carrier                       0.9377451942243763^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Charge_carrier        

matrix                        0.570713139397933^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Composite_material    

bioavailability               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bioavailability       

matrix                        0.570713139397933^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Composite_material    

absorption                    0.9999999952572125^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Absorption_(pharmacokinetics)

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

lipid                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

drug carriers                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Drug_carrier          

Biodegradable                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Biodegradation        

lipid                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

absorption                    0.9999999952572125^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Absorption_(pharmacokinetics)

industrial                    0.9999563122484508^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Industry              

nanostructured                0.6203203880714923^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Nanotechnology        

lipid                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

NLCs                          0.5538625354664546^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/1986_National_League_Championship_Series

liquid                        0.9999998700818735^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Liquid                

drug carriers                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Drug_carrier          

drugs                         0.9877298489302428^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

lipid                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

nanoparticle                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

Lipid                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

drug                          0.9896517921642789^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

lipid                         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

nanoparticle                  1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

oral drug                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Route_of_administration

bioavailability               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bioavailability       

GI                            1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Human_gastrointestinal_tract

lipophilic                    1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipophilicity         

bioavailability               1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Bioavailability       

polymeric                     1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Polymer               

lipids                        1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Lipid                 

SLN                           0.9999770725263434^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Sri_Lanka_Navy        

drug encapsulation            0.9999999999819238^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Drug_encapsulation    

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

matrix                        0.570713139397933^^http://www.w3.org/2001/XMLSchema#double            http://dbpedia.org/resource/Composite_material    

drug                          0.9896517921642789^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

biocompatible                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Biocompatibility      

absorption                    0.9999999952572125^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Absorption_(pharmacokinetics)

drugs                         0.9877298489302428^^http://www.w3.org/2001/XMLSchema#double           http://dbpedia.org/resource/Pharmaceutical_drug   

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

gastrointestinal (GI)         1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Human_gastrointestinal_tract

nanoparticles                 1.0^^http://www.w3.org/2001/XMLSchema#double                          http://dbpedia.org/resource/Nanoparticle          

